A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Healthy
Interventions
DRUG

Ursodiol 500 MG

Ursodiol 500mg tablets followed by Urso Forte 500mg tablets

DRUG

Urso Forte 500Mg Tablet

Urso forte 500mg tablets followed by Ursodiol 500mg tablets

Trial Locations (1)

6100

Pharma medica research Inc., Mississauga

All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY